These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31640885)

  • 1. Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.
    Khudina OG; Makhaeva GF; Elkina NA; Boltneva NP; Serebryakova OG; Shchegolkov EV; Rudakova EV; Lushchekina SV; Burgart YV; Bachurin SO; Richardson RJ; Saloutin VI
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126716. PubMed ID: 31640885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.
    Makhaeva GF; Elkina NA; Shchegolkov EV; Boltneva NP; Lushchekina SV; Serebryakova OG; Rudakova EV; Kovaleva NV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
    Bioorg Chem; 2019 Oct; 91():103097. PubMed ID: 31323527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase.
    Boltneva NP; Makhaeva GF; Kovaleva NV; Lushchekina SV; Burgart YV; Shchegol'kov EV; Saloutin VI; Chupakhin ON
    Dokl Biochem Biophys; 2015; 465():381-5. PubMed ID: 26728730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors.
    Shchegol'kov EV; Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Rudakova EV; Kovaleva NV; Burgart YV; Saloutin VI; Chupakhin ON; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2017 Aug; 25(15):3997-4007. PubMed ID: 28578994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Kovaleva NV; Rudakova EV; Elkina NA; Shchegolkov EV; Burgart YV; Stupina TS; Terentiev AA; Radchenko EV; Palyulin VA; Saloutin VI; Bachurin SO; Richardson RJ
    Eur J Med Chem; 2021 Jun; 218():113385. PubMed ID: 33831780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Powerful Potential of Polyfluoroalkyl-Containing 4-Arylhydrazinylidenepyrazol-3-ones for Pharmaceuticals.
    Burgart YV; Elkina NA; Shchegolkov EV; Krasnykh OP; Makhaeva GF; Triandafilova GA; Solodnikov SY; Boltneva NP; Rudakova EV; Kovaleva NV; Serebryakova OG; Ulitko MV; Borisevich SS; Gerasimova NA; Evstigneeva NP; Kozlov SA; Korolkova YV; Minin AS; Belousova AV; Mozhaitsev ES; Klabukov AM; Saloutin VI
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and testing of trifluoromethyl-containing phosphonate-peptide conjugates as inhibitors of serine hydrolases.
    Sokolova NV; Nenajdenko VG; Sokolov VB; Serebryakova OG; Makhaeva GF
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7216-8. PubMed ID: 22001085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the inhibitory effect of protostanes on human carboxylesterase 2 and their interaction: Inhibition kinetics and molecular stimulations.
    Lv X; Bai R; Yan JK; Huang HL; Huo XK; Tian XG; Zhao XY; Zhang BJ; Zhao WY; Sun CP
    Int J Biol Macromol; 2021 Jan; 167():1262-1272. PubMed ID: 33189757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Rudakova EV; Serebryakova OG; Kulikova LN; Beloglazkin AA; Borisov RS; Richardson RJ
    Bioorg Med Chem; 2018 Sep; 26(16):4716-4725. PubMed ID: 30104121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.
    Zou LW; Li YG; Wang P; Zhou K; Hou J; Jin Q; Hao DC; Ge GB; Yang L
    Eur J Med Chem; 2016 Apr; 112():280-288. PubMed ID: 26900660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
    Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
    Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives.
    Kurt BZ; Gazioglu I; Sonmez F; Kucukislamoglu M
    Bioorg Chem; 2015 Apr; 59():80-90. PubMed ID: 25706320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural inhibitor from Alisma orientale against human carboxylesterase 2: Kinetics, circular dichroism spectroscopic analysis, and docking simulation.
    Yi J; Bai R; An Y; Liu TT; Liang JH; Tian XG; Huo XK; Feng L; Ning J; Sun CP; Ma XC; Zhang HL
    Int J Biol Macromol; 2019 Jul; 133():184-189. PubMed ID: 30991064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors.
    Binder RJ; Hatfield MJ; Chi L; Potter PM
    Eur J Med Chem; 2018 Apr; 149():79-89. PubMed ID: 29499489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds.
    Wadkins RM; Hyatt JL; Edwards CC; Tsurkan L; Redinbo MR; Wheelock CE; Jones PD; Hammock BD; Potter PM
    Mol Pharmacol; 2007 Mar; 71(3):713-23. PubMed ID: 17167034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous and dietary indoles: a class of antioxidants and radical scavengers in the ABTS assay.
    Herraiz T; Galisteo J
    Free Radic Res; 2004 Mar; 38(3):323-31. PubMed ID: 15129740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient synthesis and evaluation of therapeutic potential of fluorine containing 2-arylchromen-4-ones.
    Troshkova N; Politanskaya L; Wang J; Niukalova M; Khasanov S; Esaulkova I; Zarubaev V; Boltneva N; Rudakova E; Kovaleva N; Serebryakova O; Makhaeva G; Valuisky N; Ibragimova U; Litvinov R; Babkov D; Usenov K; Chertenkov M; Pokrovsky M; Cheresiz S; Pokrovsky A
    Mol Divers; 2024 Jul; ():. PubMed ID: 39012566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility.
    Wheelock CE; Severson TF; Hammock BD
    Chem Res Toxicol; 2001 Dec; 14(12):1563-72. PubMed ID: 11743738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.